New drugs approved for rare paediatric disorders

20 Dec 2017


The EU has given approval for the use of new treatments in treating two rare paediatric endocrine disorders, primary adrenal insufficiency and X-linked hypophosphatemia.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story